Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

The Pharmafocus Interview: Martin Dawkins

September 4, 2008 Research and Development, Sales and Marketing Bayer, Cancer, NICE, Xarelto, healthcare

 Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …
Feature

Latest news from Datamonitor

September 1, 2008 Research and Development Pfizer

Pfizer: changes in R&D structure expected to increase number of late stage productsPharmaceutical giant Pfizer has announced that it intends …
News

Welcome to the real world

August 21, 2008 Research and Development clinical trials, design, observational, phase III

Feature

Europe’s largest academic health research partnership created

August 21, 2008 Research and Development, Sales and Marketing hc

Five British medical research centres and hospitals have come together to create a new academic health science partnership, the largest …
News

Drug regulation: still room for improvement

August 15, 2008 Research and Development, Sales and Marketing drug safety, medicines act

This year is a bit of a jamboree of health-related anniversaries, with the NHS celebrating 60 years and the Medicines …
Feature

Parexel seals ClinPhone deal

August 15, 2008 Research and Development

Parexel has finalised its acquisition of ClinPhone after rivals Quintiles dropped out of the race for the clinical technology firm. …
News

AstraZeneca signs Singapore cancer research deal

August 15, 2008 Research and Development AstraZeneca, Singapore, emerging markets

 AstraZeneca has signed a deal to work with Singapore’s National Cancer Centre and National University Hospital to develop new cancer …
News

Bayer boosts pre-clinical oncology pipeline

August 8, 2008 Research and Development

Bayer Schering Pharma has acquired two potential cancer drugs and a range of oncology compounds from Nycomed in a deal …
News

Latest news from Datamonitor

August 5, 2008 Research and Development, Sales and Marketing

Biovest/Accentia's BiovaxID revives hope for therapeutic cancer vaccines Biovest, a subsidiary of Accentia, has announced positive data from a pivotal …
News

Pharma-Patient group relationships

July 24, 2008 Research and Development, Sales and Marketing industry relations, patient groups, pharma

In the headlong race for global domination, pharma companies are in the process of flattening their hierarchies, slashing bureaucracy, streamlining …
Feature

PPRS reaction

July 16, 2008 Research and Development, Sales and Marketing biotech

Aisling Burnand, chief executive of the biotech representative body the BIA welcomed the deal, saying she was pleased the "months …
News

Lilly acquires SGX Pharma and drug discovery platform

July 9, 2008 Research and Development, Sales and Marketing biotech

Lilly is to buy SGX Pharmaceuticals, a biotech company that specialises in cutting-edge technology which helps drug discovery and design. …
News

Scottish marine biotech founder wins entrepreneur award

July 8, 2008 Research and Development, Sales and Marketing Scotland, biotech

The chief executive of an innovative marine biotechnology company has been named Scottish entrepreneur of the year in healthcare. Dr …
News

Almirall expands its horizons

July 3, 2008 Research and Development, Sales and Marketing Almirall, COPD, Spain

Almirall has been Spain's number one pharmaceutical company for some years, but is still little known outside its home market. …
Feature

Merck’s odanacatib shows promise in cancer

May 30, 2008 Research and Development, Sales and Marketing

Merck's odanacatib (MK-0822) has shown promising results in phase II trials in treating breast cancer which has spread to bones. …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026